Home     Research Groups   Publications     
 
MOLECULAR DIAGNOSIS & THERAPY RESEARCH GROUP
tornar



Aims


The research activity of the UDTM is linked to the commitment with the Haemophilia Unit (reference centre of congenital coagulopathies in Catalonia) in the development of molecular protocols applicable to genetic counselling and prenatal diagnosis. In-depth studies of molecular events present in some affected individuals and the relation genotype-phenotype constitute the most basic area of the laboratory objectives.

Staff


Head of Molecular Diagnosis & Therapy Research Group: Dominique Gallardo Sainz

Tel. 93 274 6725
dgallard@ir.vhebron.net
pato_terapia_grup.jpg
Researchers
Francisco Vidal Pérez
Jorge Fernando Sánchez García
Elisenda Farssac Busquets

Technical Personnel
Lorena Ramírez Orihuela

Research Areas

pato_terapia_fig1.jpg




Identification of responsible mutations of haemophilia A in the Spanish population: application to the development of therapeutic alternatives “ .
Coordinator: Francisco Vidal Pérez
Optimization of a direct sequencing procedure for the identification of mutations in the coagulation factor VIII gene. Characterization of the haemophilic population and application to the diagnosis of carrying women and to prenatal diagnosis. Creation of a database with parameters of clinical interest relating them to the mutations responsible for the pathology in our population.



pato_terapia_fig2.jpg

Direct preimplantation genetic diagnosis from polar body: application to haemophilia and other hereditary diseases.“
Responsable : Dominique Gallardo Sainz.
Development of sensitive molecular techniques capable to identify concrete mutations from the genomic material contained in a first polar body in a fast and reliable manner. Application to families affected of haemophilias A or B or to other diseases in which the causal mutation is well-known.



"
Molecular diagnosis of von Willebrand disease: study of genotype-phenotype relationship and application to the clinical diagnosis
Coordinator : Francisco Vidal Pérez
Optimization of a rapid and reliable protocol for the molecular characterization of the von Willebrand Factor gene that will allow a more precise diagnosis of the von willebrand diseae based on the identification of the mutations responsible for this coagulopathy in our population.



logo_vallhebron.jpg
logo_ics.jpg
logo_gene.jpg
logo_uab.jpg

logo_cibbim.jpg
logo_vhio.jpg
logo_bancsang.jpg
logo_farmaco.jpg
logo_cemcat.jpg
logo_idi.jpg


© Institut Recerca Hospital Universitari Vall d’Hebron
       institutrecerca@ir.vhebron.net  - Tel: +34 93 489 4337 - Fax: +34 93 489 4102
Login